GT Biopharma, Inc. Quarterly Interest Expense in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
GT Biopharma, Inc. annual/quarterly Interest Expense history and growth rate from Q2 2010 to Q2 2023.
  • GT Biopharma, Inc. Interest Expense for the quarter ending June 30, 2023 was $1K.
  • GT Biopharma, Inc. annual Interest Expense for 2023 was $213K, a 2563% increase from 2022.
  • GT Biopharma, Inc. annual Interest Expense for 2022 was $8K, a 98.9% decline from 2021.
  • GT Biopharma, Inc. annual Interest Expense for 2021 was $718K.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1K* Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $212K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2021 $718K $22K +$9.25M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$8.53M $0 -$931K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$7.6M $0 -$4.66M -100% Apr 1, 2021 Jun 30, 2021 10-Q/A 2021-12-29
Q1 2021 -$2.95M $696K +$58K +9.09% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 -$3M -$9.23M -$5.61M -155% Oct 1, 2020 Dec 31, 2020 10-K 2021-04-16
Q3 2020 $2.61M $931K +$371K +66.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.24M $4.66M +$4.18M +872% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-29
Q1 2020 -$1.94M $638K +$184K +40.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$2.13M -$3.62M -$4.76M -418% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-16
Q3 2019 $2.63M $560K -$563K -50.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $3.2M $479K -$3.45M -87.8% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-18
Q1 2019 $6.64M $454K -$2.48M -84.5% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $9.12M $1.14M +$1M +744% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $8.11M $1.12M -$2.65M -70.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $10.8M $3.92M +$2.75M +233% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $8.01M $2.93M -$589K -16.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $8.6M $135K -$1.64M -92.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $10.2M $3.77M +$2.23M +145% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $8.01M $1.18M -$421K -26.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $8.43M $3.52M +$1.87M +114% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $6.56M $1.77M -$5.25M -74.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $11.8M $1.54M -$188K -10.9% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-02-28
Q2 2016 $12M $1.6M +$750K +88.3% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-02-28
Q1 2016 $11.2M $1.65M -$5.79M -77.9% Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-02-28
Q4 2015 $17M $7.03M +$5.51M +363% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
Q3 2015 $11.5M $1.72M -$1.54M -47.2% Jul 1, 2015 Sep 30, 2015 10-Q/A 2018-02-28
Q2 2015 $13.1M $849K +$681K +405% Apr 1, 2015 Jun 30, 2015 10-Q/A 2018-02-28
Q1 2015 $12.4M $7.44M +$7.24M +3676% Jan 1, 2015 Mar 31, 2015 10-Q/A 2018-02-28
Q4 2014 $5.15M $1.52M +$1.28M +546% Oct 1, 2014 Dec 31, 2014 10-K/A 2018-02-28
Q3 2014 $3.86M $3.26M +$3.05M +1418% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $815K $168K -$47K -21.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $862K $197K -$334K -62.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $1.2M $235K -$113K -32.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $1.31M $215K +$150K +231% Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-17
Q2 2013 $1.16M $215K -$951K -81.6% Apr 1, 2013 Jun 30, 2013 10-Q 2015-01-08
Q1 2013 $2.11M $531K +$457K +618% Jan 1, 2013 Mar 31, 2013 10-Q 2015-01-08
Q4 2012 $1.65M $348K +$257K +282% Oct 1, 2012 Dec 31, 2012 10-K 2015-01-08
Q3 2012 $1.4M $65K -$52K -44.4% Jul 1, 2012 Sep 30, 2012 10-Q 2014-12-17
Q2 2012 $1.45M $1.17M +$986K +548% Apr 1, 2012 Jun 30, 2012 10-Q 2014-12-12
Q1 2012 $462K $74K -$94K -56% Jan 1, 2012 Mar 31, 2012 10-Q 2014-12-10
Q4 2011 $556K $91K Oct 1, 2011 Dec 31, 2011 10-K 2014-11-18
Q3 2011 $117K +$140K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-21
Q2 2011 $180K +$168K +1400% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-13
Q1 2011 $168K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 -$23K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 $12K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.